Compare BioNTech SE - ADR (BNTX) vs Salesforce Inc (CRM) Price & Performance

BioNTech SE - ADRTrade

Salesforce IncTrade

Price performance (Past 24H)

Key statistics

BioNTech SE - ADR vs Salesforce Inc — how do they compare? BioNTech SE - ADR trades at $89.89 (market cap $22.86B), while Salesforce Inc trades at $168 (market cap $137.23B). The key difference: Salesforce Inc is far larger — about 6× BioNTech SE - ADR's market cap, and Salesforce Inc pays a 1.05% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.

	BNTX	CRM
Market Cap	$22.86B	$137.23B
Sector	Health	Technology
52-Week High	$119.34	$270.25
52-Week Low	$83.89	$150.12
Enterprise Value	$6.53B	$167.28B
Dividend Yield	—	1.05%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

BioNTech SE - ADR

BioNTech (BNTX) trades at $90.07, down 1.55% today, amid a bearish technical signal and declining revenue trends. The company reported a net loss of $1.14 billion in 2025, with profitability metrics negative, though it maintains a strong cash position of $16.78 billion. Recent news highlights restructuring efforts, including site closures and a $1 billion share buyback, as it pivots focus to oncology pipeline development following reduced COVID-19 vaccine demand.

The outlook remains challenging with persistent losses and competitive pressures, but analyst consensus is bullish with a $129.67 price target. Key risks include execution of the oncology strategy and revenue volatility. The stock's current valuation reflects uncertainty, offering potential upside if pipeline milestones are met, but investors face significant operational and market headwinds.

Salesforce Inc

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BNTX

Head and neck squamous cell carcinoma market to grow 10.5% CAGR through 2036 with new immunotherapies.Na · 1 day agoBullish View details →

CRM

Social media analytics market to hit $107.3B by 2035 with 25.16% CAGR, driven by AI and rising social media useGlobe News Wire · 1 day agoBullish IBM warns of slowing growth as AI shifts corporate spending to infrastructure, shares plunge 25%.New York Post · 1 day agoBearish AI costs could hurt company earnings as hidden spending surprises CEOs, warns investor Chamath Palihapitiya.CNBC · 1 day agoBearish View details →

About BioNTech SE - ADR

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.

About Salesforce Inc

Salesforce Inc provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.